An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome

PURPOSE: Endoxifen concentrations have been associated with breast cancer recurrence in tamoxifen-treated patients. However, tamoxifen itself and other metabolites also show antiestrogenic anti-tumor activity. Therefore, the aim of this study was to develop a comprehensive Antiestrogenic Activity Sc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: de Vries Schultink, A. H. M., Alexi, X., van Werkhoven, E., Madlensky, L., Natarajan, L., Flatt, S. W., Zwart, W., Linn, S. C., Parker, B. A., Wu, A. H. B., Pierce, J. P., Huitema, A. D. R., Beijnen, J. H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812686/
https://ncbi.nlm.nih.gov/pubmed/28005246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4083-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky